SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies. (2022)
Attributed to:
Engineering synthetic phages against pathogenic E. coli as an innovative tool for phage therapy
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acssynbio.2c00244
PubMed Identifier: 36194543
Publication URI: http://europepmc.org/abstract/MED/36194543
Type: Journal Article/Review
Volume: 11
Parent Publication: ACS synthetic biology
Issue: 10
ISSN: 2161-5063